Insider Transactions in Q3 2022 at Tabula Rasa Health Care, Inc. (TRHC)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2022
|
Indaba Capital Management, L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
52,747
+0.8%
|
-
|
|
Sep 13
2022
|
Jonathan David Schwartz |
BUY
Grant, award, or other acquisition
|
Direct |
52,747
+50.0%
|
-
|
|
Aug 01
2022
|
Orsula V Knowlton CO-PRESIDENT |
BUY
Grant, award, or other acquisition
|
Indirect |
325,000
+31.99%
|
-
|
|
Aug 01
2022
|
Orsula V Knowlton CO-PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+29.64%
|
-
|
|
Aug 01
2022
|
Calvin H Knowlton CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Indirect |
200,000
+29.83%
|
-
|
|
Aug 01
2022
|
Calvin H Knowlton CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
325,000
+31.85%
|
-
|
|
Aug 01
2022
|
Michael Greenhalgh CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+32.42%
|
-
|
|
Aug 01
2022
|
Brian W Adams CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+31.81%
|
-
|
|
Jul 25
2022
|
Indaba Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
59,262
+0.9%
|
$237,048
$4.28 P/Share
|
|
Jul 22
2022
|
Indaba Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
293,292
+1.51%
|
$1,173,168
$4.24 P/Share
|
|
Jul 21
2022
|
Indaba Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+3.34%
|
$3,000,000
$3.92 P/Share
|